RhoA-mediated inhibition of vascular endothelial cell mobility: Positive feedback through reduced cytosolic p21 and p27

Journal of Cellular Physiology

Volumn 229, Issue 10, 2014, Pages 1455-1465

  Hsu, Yung Ho ^a   Chang, Chih Cheng ^b,c   Yang, Nian Jie ^b,c   Lee, Yi Hsuan ^d   Juan, Shu Hui ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTOMYCIN B; MATRIGEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P27; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SIMVASTATIN; SMALL INTERFERING RNA; WORTMANNIN;

ANGIOGENESIS ASSAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL MOVEMENT; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOSOL; ENDOTHELIAL CELLS; ENZYME ACTIVATORS; FEEDBACK, PHYSIOLOGICAL; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTORS, ARYL HYDROCARBON; RHO GTP-BINDING PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84903447832     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24583     Document Type: Article

References (38)

1. Abbas T, Dutta A. 2009. P21 in cancer: Intricate networks and multiple activities. Nat Rev 9:400-414.
2. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. 2006. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 20:47-64.
3. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. 2004. P27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862-876.
4. Chang CC, Lee PS, Chou Y, Hwang LL, Juan SH. 2012. Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: The therapeutic potential of statins. Am J Pathol 181:211-221.
5. Chang CC, Tsai SY, Lin H, Li HF, Lee YH, Chou Y, Jen CY, Juan SH. 2009. Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene. Cell Mol Life Sci 66:3193-3205.
6. Child ES, Mann DJ. 2006. The intricacies of p21 phosphorylation: Protein/protein interactions, subcellular localization and stability. Cell Cycle 5:1313-1319.
7. Chou Y, Lin HC, Chen KC, Chang CC, Lee WS, Juan SH. 2013. Molecular Mechanisms Underlying the Antiproliferative and Antimigratory Effects of Folate on Homocysteine-Challenged Rat Aortic Smooth Muscle Cells. Br J Pharmacol 169:1447-1460.
8. Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. 2007. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 67:9238-9243.
9. Denison MS, Whitlock JP, Jr. 1995. Xenobiotic-inducible transcription of cytochrome P450 genes. J Biol Chem 270:18175-18178.
10. Filbrandt CR, Wu Z, Zlokovic B, Opanashuk L, Gasiewicz TA. 2004. Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25:605-616.
11. Guiney PD, Smolowitz RM, Peterson RE, Stegeman JJ. 1997. Correlation of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in vascular endothelium with toxicity in early life stages of lake trout. Toxicol Appl Pharmacol 143:256-273.
12. Heron-Milhavet L, Franckhauser C, Rana V, Berthenet C, Fisher D, Hemmings BA, Fernandez A, Lamb NJ. 2006. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol Cell Biol 26:8267-8280.
13. Huggins C, Mc CJ. 1957. Regression of human metastatic mammary cancer induced by 3-methyicholanthrene. Cancer Res 17:1028-1032.
14. Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K, Okada Y. 2002. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Faseb J 16:219-221.
15. Ivnitski-Steele ID, Walker MK. 2003. Vascular endothelial growth factor rescues 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res A Clin Mol Teratol 67:496-503.
16. Juan SH, Lee JL, Ho PY, Lee YH, Lee WS. 2006. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. Eur J Pharmacol 530:1-8.
17. Kanda S, Miyata Y, Kanetake H. 2004. Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal 16:1273-1281.
18. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. 2009. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci USA 106:9268-9273.
19. Lee S, Helfman DM. 2004. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 279:1885-1891.
20. Li Y, Dowbenko D, Lasky LA. 2002. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277:11352-11361.
21. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153-1160.
22. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. 2008. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 214:434-441.
23. Ma Q, Whitlock JP, Jr. 1997. A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272:8878-8884.
24. Malins DC, Anderson KM, Gilman NK, Green VM, Barker EA, Hellstrom KE. 2004. Development of a cancer DNA phenotype prior to tumor formation. Proc Natl Acad Sci USA 101:10721-10725.
25. Massaad C, Entezami F, Massade L, Benahmed M, Olivennes F, Barouki R, Hamamah S. 2002. How can chemical compounds alter human fertility? Eur J Obstet Gynecol Reprod Biol 100:127-137.
26. McDougal A, Wormke M, Calvin J, Safe S. 2001. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator. Cancer Res 61:3902-3907.
27. Michaud SE, Menard C, Guy LG, Gennaro G, Rivard A. 2003. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway. Faseb J 17:1150-1152.
28. Nacusi LP, Sheaff RJ. 2006. Akt1 sequentially phosphorylates p27kip1 within a conserved but non-canonical region. Cell Div 1:11.
29. Paigen B, Havens MB, Morrow A. 1985. Effect of 3-methylcholanthrene on the development of aortic lesions in mice. Cancer Res 45:3850-3855.
30. Pang PH, Lin YH, Lee YH, Hou HH, Hsu SP, Juan SH. 2008. Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells. J Cell Physiol 215:161-171.
31. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Laboratory investigation. J Tech Methods Pathol 67:519-528.
32. Revis NW, Bull R, Laurie D, Schiller CA. 1984. The effectiveness of chemical carcinogens to induce atherosclerosis in the white Carneau pigeon. Toxicology 32:215-227.
33. Rosen DG, Yang G, Cai KQ, Bast RC, Jr., Gershenson DM, Silva EG, Liu J. 2005. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Clin Cancer Res 11:632-637.
34. Sekimoto T, Fukumoto M, Yoneda Y. 2004. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). EMBO J 23:1934-1942.
35. Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
36. Slingerland J, Pagano M. 2000. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10-17.
37. Tanaka H, Yamashita T, Asada M, Mizutani S, Yoshikawa H, Tohyama M. 2002. Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol 158:321-329.
38. Xu J, He L, Ahmed SH, Chen SW, Goldberg MP, Beckman JS, Hsu CY. 2000. Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke. J Cereb Circul 31:1744-1751.